Czechia· CZ-0229565
OLSSA
A olmesartan medoxomil und amlodipin product containing olmesartan medoxomil + amlodipine besilate, registered in Czechia by Krka, d.d., Novo mesto, Novo mesto. The same ATC class is registered in 8 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Olmesartan medoxomil und amlodipin is registered in 8 of 19 countries.
Countries holding a registration under ATC C09DB02 (olmesartan medoxomil und amlodipin), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 6 of them publish a price we can compare per daily dose
Olmesartan medoxomil und amlodipin · ATC C09DB02
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- OLMESARTAN MEDOXOMIL + AMLODIPINE BESILATE
- Manufacturer
- Krka, d.d., Novo mesto, Novo mesto
- Country
- Czechia (CZ)
- ATC code
- C09DB02
- ATC class
- Olmesartan medoxomil und Amlodipin
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
81 interactions on record for olmesartan medoxomil und amlodipin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olmesartan medoxomil und amlodipin · interactions on record
81 records
81 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Olmesartan medoxomil und amlodipin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAmlodipine and Olmesartan MedoxomilScieGen Pharmaceuticals, Inc
- ItalyBIVISMENARINI INTERNAT. O.L.S.A
- GermanyOlmeamloTad Pharma Gmbh
- FinlandAleaMenarini International Operations Luxembourg S.A.
- IrelandKonverge 20 mg/5 mg film-coated tabletsMenarini International Operations Luxembourg S.A.
- FranceAXELER 20 mg/5 mg, comprimé pelliculéMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Amelior, Olmesartan/Amlodipin 1a Pharma
- Belgium · Forzaten, Forzaten®
- Bulgaria · Amlodipine Besilate / Olmesartan Medoxomil Viatris Limited, Амлосарт
- Cyprus · Alsamod, Comprelan
- Germany · Olmeamlo, Olmeamlodipin Puren
- Estonia · Olmesartan Medoxomil/Amlodipine Accord, Olmesartan Medoxomil/Amlodipine Zentiva
- Spain · Albis, Balzak
- Finland · Olmesartan Medoxomil/Amlodipine Krka
- France · Axeler, Sevikar
- United Kingdom (Northern Ireland) · Olmesartan Medoxomil And Amlodipine Clydesdale Pharma, Olmesartan Medoxomil/Amlodipine Accord Healthcare
- Greece · Comprelan, Olmedipin
- Croatia · Olmita
- Hungary · Duactan, Olmiza
- Ireland · Konverge, Olmesartan /Amlodipine Mylan
- Italy · Bivis, Giant
- Lithuania · Olmesartan Medoxomil /Amlodipine Sandoz, Olmesartan Medoxomil/Amlodipine Accord
- Luxembourg · Forzaten, Olmesartan/Amlodipine Eg
- Latvia · Olmesartan Medoxomil/ Amlodipine Zentiva, Olssa
- Malta · Konverge, Olmesartan Medoxomil/Amlodipine Ascend
- Netherlands · Amlodipine Besylate/ Olmesartan Medoxomil Aurobindo, Amlodipine Besylate/Olmesartan Medoxomil Aurobindo
- Poland · Elestar, Olmita
- Portugal · Amlodipina + Olmesartan Medoxomilo Alter, Amlodipina + Olmesartan Medoxomilo Aurovitas
- Romania · Almacor Duo, Inovum
- Slovenia · Olectan, Olmita
- Slovakia · Folgan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ad1fa54a-dafa-4e05-a4e0-2df97de4d327 GET /v1/drugs/ad1fa54a-dafa-4e05-a4e0-2df97de4d327?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "40MG/10MG",
"pack_size": "14",
"substance": "OLMESARTAN MEDOXOMIL + AMLODIPINE BESILATE",
"cz_kod_sukl": "0229565",
"product_type": "CH",
"substance_codes": "15600,12990",
"registration_state": "R",
"registration_number": "58/706/16-C"
}See everything about olmesartan medoxomil und amlodipin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.